Catatonia #101
Catatonia is not just mutism or withdrawal; it is a motor syndrome that PMHNPs must recognize early.
Key Motor Signs of Catatonia: What They Actually Mean
Waxy Flexibility
Patient’s limbs remain in positions they are placed, like bending warm wax.
Posturing
Spontaneous maintenance of abnormal or uncomfortable body positions for long periods.
Catalepsy
Passive induction of a posture held rigidly against gravity.
Gegenhalten (Paratonia)
Variable resistance to passive movement that increases as more force is applied.
Mitgehen
Exaggerated movement in response to minimal pressure, even when instructed not to move.
Stereotypies
Repetitive, non-goal-directed movements (e.g., rocking, hand flapping).
Mannerisms
Odd, exaggerated, or distorted versions of normal movements or gestures. These motor signs help distinguish catatonia from severe psychosis or depression.
When the diagnosis is unclear, benzodiazepines should come before antipsychotics. Antipsychotics can worsen catatonia and increase the risk of malignant catatonia.
Early recognition, motor-focused assessment, and timely treatment change outcomes and save lives.
As a practicing psychiatric mental health nurse practitioner, I’ve encountered several cases where early recognition of catatonia was critical to patient outcomes. One of the challenges in clinical settings is distinguishing catatonia from severe psychosis or depression, especially when symptoms like mutism or withdrawal are present without obvious motor signs. What truly sets catatonia apart is its complex motor syndrome—as described by symptoms like waxy flexibility, where a patient’s limbs feel as though molded in warm wax, or catalepsy, involving rigidly held postures against gravity. During assessments, it is vital to remain patient and comfortable with silence. I have found myself waiting up to a full minute watching for subtle motor responsiveness, which can feel uncomfortable initially but is necessary to avoid misinterpretation due to anxiety or external prompts. A motor-focused examination complements traditional psychiatric evaluation and often includes validated tools like the Bush Francis Catatonia Rating Scale that track symptom changes over time. In terms of treatment, my experience aligns with best practices—starting with benzodiazepines, primarily lorazepam, which can often serve as both diagnostic and therapeutic agents. Many catatonic patients tolerate higher doses without excessive sedation, but careful monitoring is required, particularly for older adults or medically fragile individuals. Importantly, I avoid prescribing antipsychotics initially if catatonia is suspected, as they may worsen symptoms or even trigger malignant catatonia, a medical emergency. When benzodiazepines are insufficient, electroconvulsive therapy (ECT) has proven highly effective in my practice and is supported by research. For patients where ECT is unavailable, NMDA receptor antagonists like memantine have shown promise. Long-term management may require slow tapering of benzodiazepines to prevent relapse and sometimes low-dose maintenance therapy. Overall, catatonia should never be overlooked or mistaken for mere psychiatric withdrawal. Early recognition backed by thorough motor assessment and timely treatment initiation not only improves recovery but also saves lives. Sharing these insights and practical tips with fellow PMHNPs helps build confidence in managing this complex condition effectively.